Ending drug companies' addiction to price rises

Article

NEW YORK (Reuters) - Drug companies are dosing up on price increases to prop up stagnant sales, but will soon need to break that addiction as more medicines face generic competition.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image Credit: jokekung - stock.adobe.com
Image Credit: gamelover - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.